Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Long101on Apr 29, 2021 10:57am
255 Views
Post# 33090828

R-107 mention on a PAH website

R-107 mention on a PAH websiteHello, I'm a relatively new clas stockholder; bought in early March, soon after kly resumed trading. Basically, I'm a forum "stalker" not a poster, and really appreciate those of you who add value to the conversation. I ignore the rest.

I just stumbled onto a PAH website with a nice mention of R-107, so thought I would share. Not sure if anyone shared the link already, so my appologies if has already been posted. It doesn't add any new info to the mix, but it's good to see word getting out. https://pulmonaryhypertensionnews.com/2021/04/23/claritas-acquiring-global-rights-r107-varied-nitric-oxide-pah-therapy/ 

Cheers!
<< Previous
Bullboard Posts
Next >>